BCI Atlas

The Chinese company sponsoring the NEO wireless epidural BCI trial, which the NEO device entry reports as the first implantable BCI with market approval.

Company — Chinese

Neuracle

Official site → Shanghai, China

BCI · company · China · NEO · epidural · wireless · secondary region

Last reviewed against public sources: Oct 6, 2026

Neuracle is the sponsor of the NEO clinical trial. The ClinicalTrials.gov record lists the lead sponsor as Neuracle Medical Technology (Shanghai) Co., Ltd.

Trial record: https://clinicaltrials.gov/study/NCT06990412
Company site: https://www.neuracle.cn/

The NEO trial (registry record)

Official title: a prospective, multi-center clinical trial of the implantable wireless BCI system NEO in patients with tetraplegia, to provide a basis for product registration.
Status Completed. Start 28 May 2025, primary completion 6 November 2025, completion 10 January 2026.
Collaborating hospitals include Huashan Hospital, Xuanwu Hospital Beijing, Beijing Tiantan Hospital and West China Hospital, among others.

Device entries

NEO wireless epidural BCI (Neuracle, Tsinghua)
Related China entry: Beinao-1

Limits

China entry, secondary region. The company’s own site was rate-limited when checked, so this brief relies on the registry record.